Munehisa Shimamura

J-GLOBAL         Last updated: Jul 10, 2019 at 22:26
 
Avatar
Name
Munehisa Shimamura

Research Areas

 
 
  • Clinical internal medicine / Neurology / 

Published Papers

 
Shimamura M, Nakagami H
Expert review of vaccines   18(5) 419-421   May 2019   [Refereed]
Shimamura M, Shinzaki S, Ikenaka K, Konaka K, Hirozawa D, Ishikura T, Hideshima M, Nakano T, Kitano T, Takehara T, Mochizuki H
Rinsho shinkeigaku = Clinical neurology   59(3) 153-156   Mar 2019   [Refereed]
Kanki H, Sasaki T, Matsumura S, Yokawa S, Yukami T, Shimamura M, Sakaguchi M, Furuno T, Suzuki T, Mochizuki H
Cell death & disease   10(2) 100   Feb 2019   [Refereed]
Kawano T, Shimamura M, Nakagami H, Kanki H, Sasaki T, Mochizuki H
PloS one   14(5) e0215482   2019   [Refereed]
Shimamura M, Nakagami H, Shimizu H, Mukai H, Watanabe R, Okuzono T, Kawano T, Ikeda Y, Hayashi H, Yoshida S, Ju N, Mochizuki H, Morishita R
Scientific reports   8(1) 17770   Dec 2018   [Refereed]

Misc

 
Zhengda Pang, Akifumi Kushiyama, Jiao Sun, Takako Kikuchi, Hiroki Yamazaki, Yasuhiko Iwamoto, Hiroshi Koriyama, Shota Yoshida, Munehisa Shimamura, Masayoshi Higuchi, Tomohiro Kawano, Yoichi Takami, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami
FASEB Journal   31 4053-4063   Sep 2017
© FASEB. Glial fibrillary acidic protein (GFAP) is expressed in peri-islet Schwann cells, as well as in glia cells, and has been reported to be an autoantigen candidate for type 1 diabetes mellitus (T1DM). We confirmed that the production of the a...
Gillipsie Minhas, Sudesh Prabhakar, Ryuichi Morishita, Munehisa Shimamura, Reema Bansal, Akshay Anand
Molecular and Cellular Biochemistry   429 123-136   May 2017
© 2017, Springer Science+Business Media New York. Retinal ischemia is a condition associated with retinal degenerative diseases such as glaucoma, diabetic retinopathy, and other optic neuropathies, leading to visual impairment and blindness worldw...
Kouji Wakayama, Munehisa Shimamura, Jun Ichi Suzuki, Ryo Watanabe, Hiroshi Koriyama, Hiroshi Akazawa, Hironori Nakagami, Hideki Mochizuki, Mitsuaki Isobe, Ryuichi Morishita
Stroke   48 1362-1368   May 2017
© 2017 American Heart Association, Inc. Background and Purpose - Medication nonadherence is one of major risk factors for the poor outcome in ischemic stroke. Vaccination is expected to solve such a problem because of its long-lasting effects, but...
Ryo Watanabe, Jun Ichi Suzuki, Kouji Wakayama, Yasuhiro Maejima, Munehisa Shimamura, Hiroshi Koriyama, Hironori Nakagami, Hidetoshi Kumagai, Yuichi Ikeda, Hiroshi Akazawa, Ryuichi Morishita, Issei Komuro, Mitsuaki Isobe
Scientific Reports   7    Mar 2017
© The Author(s) 2017. A peptide vaccine targeting angiotensin II (Ang II) was recently developed as a novel treatment for hypertension to resolve the problem of noncompliance with pharmacotherapy. Ang II plays a crucial role in the pathogenesis of...
Zhengda Pang, Masayoshi Higuchi, Hiroshi Koriyama, Shota Yoshida, Hitomi Kurinami, Munehisa Shimamura, Yoichi Takami, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami
FEBS Letters   591 129-136   Jan 2017
© 2016 Federation of European Biochemical Societies Glial fibrillary acidic protein (GFAP), expressed in peri-islet Schwann cells, is a novel target for the treatment of type 1 diabetes mellitus (T1DM). We designed a GFAP immune-tolerizing vaccine...